Title:
IMPROVED ANTI-FIBRONECTIN EDA ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2019/212341
Kind Code:
A8
Abstract:
The disclosure concerns antibodies that bind fibronectin-EDA. These antibodies are particularly useful for use in treatment, prevention, or prevention of progression of fibrosis, adverse cardiac remodeling and conditions resulting from or relating to myocardial infarction and pressure-overload, such as heart failure, aneurysm formation and remote myocardial fibrosis and for use in improving angiogenesis, preferably after ischemic injury.
Inventors:
ADANG ANTON EGBERT PETER (NL)
ARSLAN FATIH (NL)
ARSLAN FATIH (NL)
Application Number:
PCT/NL2019/050253
Publication Date:
January 09, 2020
Filing Date:
May 01, 2019
Export Citation:
Assignee:
ENCARE BIOTECH B V (NL)
International Classes:
C07K16/18; A61P9/10
Attorney, Agent or Firm:
WITMANS, H.A. (NL)
Download PDF:
Previous Patent: NUT FOR A PARASOL FOOT AND ASSEMBLY
Next Patent: A DIRECT CURRENT TO DIRECT CURRENT ELECTRIC POWER CONVERTER
Next Patent: A DIRECT CURRENT TO DIRECT CURRENT ELECTRIC POWER CONVERTER